Analysts Set HealthEquity, Inc. (NASDAQ:HQY) PT at $101.42

Shares of HealthEquity, Inc. (NASDAQ:HQY) have received an average recommendation of “Buy” from the twelve brokerages that are currently covering the firm, MarketBeat reports. Twelve investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $101.67.

Several brokerages have recently commented on HQY. KeyCorp increased their price objective on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 5th. Barrington Research increased their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. Bank of America upped their target price on HealthEquity from $97.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, June 4th. JMP Securities upped their target price on HealthEquity from $101.00 to $105.00 and gave the company a “market outperform” rating in a report on Tuesday, June 4th. Finally, BTIG Research upped their target price on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, March 20th.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Evelyn S. Dilsaver sold 32,500 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the transaction, the director now directly owns 32,123 shares of the company’s stock, valued at $2,547,032.67. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Director Evelyn S. Dilsaver sold 32,500 shares of the firm’s stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the completion of the transaction, the director now directly owns 32,123 shares of the company’s stock, valued at $2,547,032.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Vice Chairman Stephen Neeleman sold 2,080 shares of the firm’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $85.01, for a total value of $176,820.80. Following the completion of the transaction, the insider now directly owns 90,515 shares of the company’s stock, valued at $7,694,680.15. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 34,980 shares of company stock valued at $2,787,746. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently made changes to their positions in HQY. Cape Investment Advisory Inc. purchased a new stake in HealthEquity during the fourth quarter valued at about $27,000. Rise Advisors LLC purchased a new stake in HealthEquity during the first quarter valued at about $28,000. McGlone Suttner Wealth Management Inc. purchased a new stake in HealthEquity during the fourth quarter valued at about $29,000. YHB Investment Advisors Inc. purchased a new stake in HealthEquity during the first quarter valued at about $40,000. Finally, DekaBank Deutsche Girozentrale purchased a new stake in HealthEquity during the third quarter valued at about $41,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Up 1.7 %

HQY stock opened at $83.64 on Wednesday. The company has a market cap of $7.28 billion, a P/E ratio of 90.91, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. HealthEquity has a fifty-two week low of $59.02 and a fifty-two week high of $87.72. The stock’s 50 day simple moving average is $80.67 and its 200 day simple moving average is $77.53. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.39 and a current ratio of 4.39.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.42 by $0.08. The firm had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. On average, research analysts expect that HealthEquity will post 2.12 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.